MedTrace Logo

CSF/Serum Biomarkers in Predicting PND/Persistent Pain After Cesarean

NCT04271072 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2023-12-20

No results posted yet for this study

Summary

The aim is to investigate if inflammatory biomarkers in the blood and cerebrospinal fluid (CSF) are associated with the development of perinatal depression and/or persistent pain after cesarean delivery.

This study will obtain CSF and blood samples in 70 parturients. All parturients will be assessed for perinatal depression and persistent pain, and the presence/absence of these outcomes will be correlated to changes in the inflammatory biomarkers within the samples collected. If present, consistent changes in biomarkers correlating with perinatal depression or persistent pain may be utilised as a predictive tool and facilitate early treatment for these conditions.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

Principal Investigators

  • Mary Yurashevich · Duke University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04271072 on ClinicalTrials.gov